LITE NFOAMY HEALTHCARE PERSONNEL HANDWASH Lite'n Foamy Healthcare Personnel Handwash recall — FDA D-0364-2021
CGMP Deviations
Browse U.S. drug recall enforcement reports from the FDA in a structured, searchable format. Review the recalled product, reason, firm, status, dates, distribution information and FDA classification when available.
10,685 detailed records are currently available in this category.
CGMP Deviations
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
CGMP Deviations
Microbial Contamination of Non-Sterile Products; lot tested positive for Bulkholderia multivorans
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
CGMP Deviations
Failed Moisture Limits: Out of specification for water content
An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.
An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.
An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.
Labeling; Label Mix-up; some bottles containing Foam Skin Cleanser soap are incorrectly labeled as Moisturizing Foam Hand Sanitizer
Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate
Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.
Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.
Crystallization: customer complaints for crystallization in finished product.
Crystallization: customer complaints for crystallization in finished product.
Presence of particulate matter.one confirmed customer report of particulate matter within two semi-rigid bottles identified prior to use
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.
Failed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturer
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.
Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets.
Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing
Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.